How to buy AVITA Medical stock - 21 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy AVITA Medical stock

Own AVITA Medical stock in just a few minutes.

AVITA Medical, Inc is a medical devices business based in the US. AVITA Medical shares (RCEL) are listed on the NASDAQ and all prices are listed in US Dollars. AVITA Medical employs 98 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in AVITA Medical

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – RCEL – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

AVITA Medical share price

Use our graph to track the performance of RCEL stocks over time.

AVITA Medical shares at a glance

Information last updated 2021-04-16.
52-week range$16.87 - $34.90
50-day moving average $21.31
200-day moving average $22.52
Wall St. target price$41.60
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.03

Buy AVITA Medical shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Gold/Commodities
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy AVITA Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

AVITA Medical financials

Revenue TTM $17.9 million
Gross profit TTM $11.3 million
Return on assets TTM -33.62%
Return on equity TTM -59.9%
Profit margin -244.63%
Book value N/A
Market capitalisation $526.9 million

TTM: trailing 12 months

Shorting AVITA Medical shares

There are currently 822,572 AVITA Medical shares held short by investors – that's known as AVITA Medical's "short interest". This figure is 101.6% up from 408,041 last month.

There are a few different ways that this level of interest in shorting AVITA Medical shares can be evaluated.

AVITA Medical's "short interest ratio" (SIR)

AVITA Medical's "short interest ratio" (SIR) is the quantity of AVITA Medical shares currently shorted divided by the average quantity of AVITA Medical shares traded daily (recently around 221121.50537634). AVITA Medical's SIR currently stands at 3.72. In other words for every 100,000 AVITA Medical shares traded daily on the market, roughly 3720 shares are currently held short.

However AVITA Medical's short interest can also be evaluated against the total number of AVITA Medical shares, or, against the total number of tradable AVITA Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AVITA Medical's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 AVITA Medical shares in existence, roughly 30 shares are currently held short) or 0.0336% of the tradable shares (for every 100,000 tradable AVITA Medical shares, roughly 34 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against AVITA Medical.

Find out more about how you can short AVITA Medical stock.

AVITA Medical share dividends

We're not expecting AVITA Medical to pay a dividend over the next 12 months.

Have AVITA Medical's shares ever split?

AVITA Medical's shares were split on a 1:5 basis on 29 June 2020. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your AVITA Medical shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for AVITA Medical shares which in turn could have impacted AVITA Medical's share price.

AVITA Medical share price volatility

Over the last 12 months, AVITA Medical's shares have ranged in value from as little as $16.87 up to $34.9. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AVITA Medical's is 0.4651. This would suggest that AVITA Medical's shares are less volatile than average (for this exchange).

AVITA Medical overview

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa; and a research collaboration with Houston Methodist Research Institute to explore novel approaches for skin rejuvenation. The company was formerly known as AVITA Therapeutics, Inc.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site